Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

Yousef Al-Shraideh*, Samir V. Sejpal, Joshua J Meeks

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

Original languageEnglish (US)
Title of host publicationProstate Cancer
Subtitle of host publicationScience and Clinical Practice: Second Edition
PublisherElsevier Inc
Pages275-280
Number of pages6
ISBN (Print)9780128000779
DOIs
StatePublished - Dec 3 2015

Fingerprint

Prostatectomy
Prostatic Neoplasms
Radiotherapy
Radiation
Recurrence
Salvage Therapy
Neoplasms
Biomarkers
Incidence
Therapeutics

Keywords

  • PSA
  • Prostate cancer
  • Radiation treatment
  • Radical prostatectomy
  • Surgery

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Al-Shraideh, Y., Sejpal, S. V., & Meeks, J. J. (2015). Radiation-Resistant Prostate Cancer and Salvage Prostatectomy. In Prostate Cancer: Science and Clinical Practice: Second Edition (pp. 275-280). Elsevier Inc. https://doi.org/10.1016/B978-0-12-800077-9.00031-1
Al-Shraideh, Yousef ; Sejpal, Samir V. ; Meeks, Joshua J. / Radiation-Resistant Prostate Cancer and Salvage Prostatectomy. Prostate Cancer: Science and Clinical Practice: Second Edition. Elsevier Inc, 2015. pp. 275-280
@inbook{a956c0b6bef046b3a99f8f45670c517b,
title = "Radiation-Resistant Prostate Cancer and Salvage Prostatectomy",
abstract = "One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.",
keywords = "PSA, Prostate cancer, Radiation treatment, Radical prostatectomy, Surgery",
author = "Yousef Al-Shraideh and Sejpal, {Samir V.} and Meeks, {Joshua J}",
year = "2015",
month = "12",
day = "3",
doi = "10.1016/B978-0-12-800077-9.00031-1",
language = "English (US)",
isbn = "9780128000779",
pages = "275--280",
booktitle = "Prostate Cancer",
publisher = "Elsevier Inc",

}

Al-Shraideh, Y, Sejpal, SV & Meeks, JJ 2015, Radiation-Resistant Prostate Cancer and Salvage Prostatectomy. in Prostate Cancer: Science and Clinical Practice: Second Edition. Elsevier Inc, pp. 275-280. https://doi.org/10.1016/B978-0-12-800077-9.00031-1

Radiation-Resistant Prostate Cancer and Salvage Prostatectomy. / Al-Shraideh, Yousef; Sejpal, Samir V.; Meeks, Joshua J.

Prostate Cancer: Science and Clinical Practice: Second Edition. Elsevier Inc, 2015. p. 275-280.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

AU - Al-Shraideh, Yousef

AU - Sejpal, Samir V.

AU - Meeks, Joshua J

PY - 2015/12/3

Y1 - 2015/12/3

N2 - One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

AB - One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

KW - PSA

KW - Prostate cancer

KW - Radiation treatment

KW - Radical prostatectomy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84966769133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966769133&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800077-9.00031-1

DO - 10.1016/B978-0-12-800077-9.00031-1

M3 - Chapter

SN - 9780128000779

SP - 275

EP - 280

BT - Prostate Cancer

PB - Elsevier Inc

ER -

Al-Shraideh Y, Sejpal SV, Meeks JJ. Radiation-Resistant Prostate Cancer and Salvage Prostatectomy. In Prostate Cancer: Science and Clinical Practice: Second Edition. Elsevier Inc. 2015. p. 275-280 https://doi.org/10.1016/B978-0-12-800077-9.00031-1